# FDA recall D-155-2013

> **Matrixx Initiatives Inc** · Class I · drug recall initiated 2012-12-18.

## Product

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona  85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

## Reason for recall

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-155-2013
- **Recalling firm:** Matrixx Initiatives Inc
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-12-18
- **Report date:** 2013-02-13
- **Termination date:** 2013-11-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Scottsdale, AZ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-155-2013

## Citation

> AI Analytics. FDA recall D-155-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-155-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*